About Steve Reitmeister
Steve Reitmeister is the CEO of StockNews.com, bringing 40 years of experience to help individual investors find outperformance. For the better part of the past two decades he was the Editor-in-Chief of Zacks.com where millions of investors enjoyed his timely market insights. His commentary has also been featured on other leading investment websites including Yahoo Finance, SeekingAlpha, CNNMoney and MarketWatch. Steve has an MBA from DePaul University and B.A. in Economics from the University of Wisconsin (Go Badgers!).
Steve is also the Editor of the Reitmeister Total Return portfolio service. This is where he puts those 40 years of experience to work for you in selecting the best trades for the current market environment. See the Reitmeister Total Return portfolio.
Recent Articles By Steve Reitmeister
7 Safest Stocks for this Volatile Market
Now is the time to consider safer stocks like AbbVie. Plenty of reason for them to run during the good times. But the right qualities to outperform when the storm clouds emerge over the market. Discover all 7 of the best safe stocks below.
10 Perfect Stocks for October
Citigroup is one of 10 stocks that combine an attractive blend of growth, value, income and momentum.
Should Investors Be More Scared?
Why is the S&P (SPY) rallying on such weak economic data? And what is the game plan coming into the 10/10 round of trade talks? The answers are shared below.
Replay: 10/1 Reitmeister's Strategy Session Webinar
The upcoming trade talks and weak ISM Manufacturing reports spells downside risk for SPY and the rest of the market. That is why my stock of the week is an inverse ETF. Learn more below.
The Stock of the Week...is NOT a Stock
Maybe you should be a bit more defensive coming into the October 10th China trade meetings. And maybe HDGE is the perfect choice to protect yourself against potential market downside.
Top 5 Stocks from the #1 Ranked Industry
Discover why Money Center Banks are the #1 industry and why JP Morgan (JPM) sits atop the industry with a Strong Buy rating.
Investors: Welcome to Limbo Land
What is the S&P (SPY) likely to do into the October 10th trade negotiations...and afterwards...and what is your investment strategy??? Let's discuss it all below.
10 Best Stocks Under $10
Antares Pharma is one of 10 stand out stocks trading under $10...but maybe not for long. Find out what makes these low priced stocks so special.
What is the Worst Case Scenario for Stocks?
We need to consider just how bad things would get for the S&P (SPY) if the China deal fell apart. Yes, other indices would likely take it even harder. Let's review how this would likely unfold and our trading strategies.